NFKB1 and coronary artery disorder: Since both IL-6 and IL-8 are known to phosphorylate the STAT3 and IL-10 is known to inhibit the NF-κB p65 signaling pathways, we investigated the inflammatory signaling pathways induced in the THP-1 macrophages by these inflammatory mediators in our CHD cohort.